期刊文献+

封管用枸橼酸钠注射液体外抑菌作用研究 被引量:1

In vitro bacteriostatic activity of the sodium citrate injection for catheter locking
原文传递
导出
摘要 目的:评价封管用枸橼酸钠注射液的体外抑菌作用,并与肝素钠注射液作用进行比较。方法:采用琼脂稀释法和肉汤稀释法测定封管用枸橼酸钠注射液对204株标准及临床分离菌的最低抑菌浓度(MIC),以琼脂打洞扩散法与目前临床使用的肝素钠封管液进行抑菌效果比较。结果:封管用枸橼酸钠注射液对金葡球菌、表皮葡萄球菌、大肠埃希菌、铜绿假单胞菌及白色念珠球菌的MIC范围分别为58.4~7.3,29.2~7.3,233.5~116.8,233.5~58.4与58.4~29.2mg.mL-1;抑菌圈直径分别为2.6,2.8,1.2,4.4及2.4cm,而肝素无抑菌圈。结论:封管用枸橼酸钠注射液对留置导管感染常见病原菌具有良好的抑菌作用,有望成为替代肝素的新一代理想封管液。 Objective:To evaluate the in vitro antibacterial activity of the sodium citrate injection for catheter locking.Methods:The agar dilution method and broth dilution test were used to determine the minimal inhibitory concentrations (MIC) of the sodium citrate injection for catheter locking in 204 standard strains and clinical isolated strains.Agar diffusion method was applied to compare the antimicrobial efficacy of sodium citrate injection with that of heparin sodium injection.Results:The MIC ranges of sodium citrate injection against Staphylococcus aureus,Staphylococcus epidermidis,Escherichia coli,Pseudomonas aeruginosa and Candida albicans were 58.4~7.3,29.2~7.3,233.5~116.8,233.5~58.4 and 58.4~29.2 mg·mL^-1,respectively.The diameters of inhibition zone were 2.6,2.8,1.2,4.4 and 2.4 cm.On the other hand,heparin sodium injection was proved to show no antimicrobial effect of any significance by agar diffusion method.Conclusion:The sodium citrate injection for catheter locking has favorable antimicrobial effect against pathogens for infection of indwelling catheter,and is a promising substitute for heparin sodium injection.
出处 《中国新药杂志》 CAS CSCD 北大核心 2010年第7期625-627,共3页 Chinese Journal of New Drugs
关键词 枸橼酸钠 药敏试验 抑菌活性 sodium citrate drug sensitive test bacteriostatic activity
  • 相关文献

参考文献4

二级参考文献15

  • 1花天放.中心静脉导管性败血症[J].上海医学,1989,12(1):55-57. 被引量:10
  • 2Des Jardin JA,Falagas ME,Ruthazer R,et al.Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer[J].Ann Intern Med,1999,131(9) :641-647.
  • 3Viale P,Pagani L,Petrosillo N,et al.Antibiotic lock-technique for the treatment of catheter-related bloodstream infections[J].J Chemother,2003,15(2) :152-156.
  • 4Suhocki PV, Conlon PJ Jr, Knelson MH, et al. Silastic cuffed catheters for hemodialysis vascular access:thrombolytic and mechanical correction of malfunction. Am J Kidney Dis, 1996, 28: 379-386.
  • 5Marcel CW, Yvette JD, Francien JV, et al. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant, 2002, 17:2189-2195.
  • 6Sodemann K, Polaschegg HD, Feldmer B. Two years' experience with Dialock and CLS (a new antimicrobial lock solution). Blood Purif, 2001, 19:251-254.
  • 7Meeus G, Kuypers DR, Claes K, et al. A prospective,randomized, double-blind crossover study on the use of 5%citrate lock versus 10% citrate lock in permanent hemodialysis catheters. Blood Purif, 2005, 23: 101-105.
  • 8Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol, 2002, 13:2133-2139.
  • 9NKF. K/DOQ1 clinical practice guidelines for vascular access,2000. Am J Kidney Dis, 2001, 37 Suppl 1: S137-S181.
  • 10Marcel CW, Marinus AD, Peter JGV, et al. Randomized,clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.J Am Soc Nephrol, 2005, 16: 2769-2777.

共引文献45

同被引文献12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部